Gliflozins in the Management of Cardiovascular Disease

Samuel N. Heyman, Zaid Abassi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)477-478
Number of pages2
JournalNew England Journal of Medicine
Issue number5
StatePublished - 4 Aug 2022


  • Cardiovascular Diseases/prevention & control
  • Diabetes Mellitus, Type 2
  • Humans
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors/therapeutic use

ASJC Scopus subject areas

  • General Medicine

Cite this